126813-46-5

Upstream product

• 57260-73-8 N-BOC-1,2-diaminoethane 
• 97-08-5 3-nitro-4-chlorosulfonyl chloride 

Downstream Products

• 135685-03-9 N-<2-<<(1,1-dimethylethoxy)carbonyl>amino>ethyl>-4-hydroxy-3-nitrobenzenesulfonamide 
• 126813-47-6 N-<2-<<(1,1-dimethylethoxy)carbonyl>amino>ethyl>-N-methyl-4-chloro-3-nitrobenzenesulfonamide 
• 126813-49-8 N-<2-<<(1,1-dimethylethoxy)carbonyl>amino>ethyl>-N-methyl-3-nitro-4-(1-methyl-1-nitroethyl)benzenesulfonamide 
• 126813-48-7 N-<2-<<(1,1-dimethylethoxy)carbonyl>amino>ethyl>-N-methyl-3-nitro-4-(4-nitrophenoxy)benzenesulfonamide 
• 126813-43-2 N-(2-aminoethyl)-N-methyl-3-nitro-4-(1-methyl-1-nitroethyl)benzenesulfonamide hydrochloride 

Relevant academic research and scientific papers

Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy

Ferroptosis is an iron-catalyzed, nonapoptotic form of regulated necrosis that results in oxidative lipid damage in cell membranes that can be inhibited by the radical-trapping antioxidant Ferrostatin-1 (Fer-1). Novel inhibitors derived from the Fer-1 sca

3-(BENZYLAMINO)-4-(CYCLOHEXYLAMINO)-N-(2-(PIPERAZIN-1-YL)ETHYL)BENZENESULFONAMIDE DERIVATIVES AND RELATED FERROSTATIN-1 ANALOGUES AS CELL DEATH INHIBITORS FOR TREATING E.G. STROKE

The present invention relates to 3-(benzylamino)-4-(cyclohexylamino)-N-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 (Fer-1) analogues as cell death inhibitors by inhibition of ferroptosis and/or oxytosis for the treatm

Synthesis and evaluation of some nitrobenzenesulfonamides containing nitroisopropyl and (ureidooxy)methyl groups as novel hypoxic cell selective cytotoxic agents

Basic nitrobenzenesulfonamides containing nitroisopropyl and (ureidooxy)methyl groups were prepared and evaluated as novel hypoxic cell selective cytotoxic agents. In vitro, N-(2-aminoethyl)-N-methyl-3-nitro-4-(1-methyl-1-nitroethyl) benzenesulfonamide hy